Search results for " vaccines"

showing 10 items of 472 documents

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).

2011

Background: Heptavalent pneumococcal conjugate vaccine (PCV-7) was licensed to provide immunity against pneumococcal disease caused by seven serotypes of S. pneumoniae. Thirteen-valent pneumococcal conjugate vaccine (PCV-13) includes 6 additional serotypes for preventing invasive pneumococcal disease. Objective: The objective of this study was to estimate the potential health benefits, costs, and cost-effectiveness of vaccination with PCV-13 in the Community of Valencia and to generate valuable information for policy makers at regional and country levels. Methods: A decision tree was designed to determine the health and economic outcomes in hypothetical cohorts of vaccinated and unvaccinate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCost effectivenessPharmacoeconomic assessmentCost-Benefit AnalysisPneumococcal conjugate vaccinePneumococcal InfectionsHerd immunityPneumococcal VaccinesIndirect costsYoung AdultEnvironmental healthmedicineHeptavalent Pneumococcal Conjugate VaccineHumansChildAgedAged 80 and overGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPneumococcal conjugate vaccineVaccinationPublic Health Environmental and Occupational HealthInfant NewbornInfantMiddle AgedQuality-adjusted life yearVaccinationInfectious DiseasesSpainChild PreschoolCohortMolecular MedicineCost-effectivenessFemalebusinessmedicine.drugVaccine
researchProduct

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccinatio…

2009

Priming a population with a pre-pandemic vaccine is being considered to maximize the response upon subsequent vaccination with a true pandemic vaccine more closely matched to the causative pandemic strain. The present study explored this prime-boost concept by evaluating different primary schedules with the pre-pandemic A/Vietnam/1194/2004(NIBRG-14) vaccine, containing 3.75 microg of HA, followed by a 6-month booster with a vaccine formulated with 3.75 microg HA of either the same strain or with A/Indonesia/05/2005(IBCDC-RG2), a heterologous strain from a different clade. In this multicentre, open, randomized study (NCT00430521) we measured immune responses in four groups (N = 48-60) of adu…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCross Protectionmedicine.medical_treatmentPopulationImmunization SecondaryBooster doseAntibodies ViralYoung AdultAdjuvants ImmunologicImmunityInfluenza Humanparasitic diseasesmedicineHumansAS03educationeducation.field_of_studyBooster (rocketry)Influenza A Virus H5N1 SubtypeGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthHemagglutination Inhibition TestsMiddle AgedImmunity HumoralVaccinationInfectious DiseasesImmunizationInfluenza VaccinesImmunologyMolecular MedicineFemalebusinessAdjuvantVaccine
researchProduct

Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

2014

Background: Meningococcal C (MenC) conjugate vaccines have controlled invasive diseases associated with this serogroup in countries where they are included in National Immunization Programs and also in an extensive catch-up program involving subjects up to 20 years of age. Catch-up was important, not only because it prevented disease in adolescents and young adults at risk, but also because it decreased transmission of the bacteria, since it was in this age group where the organism was circulating. Our objective is to develop a new vaccination schedule to achieve maximum seroprotection in these groups. Methods: A recent study has provided detailed age-structured information on the seroprote…

AdultMalePediatricsmedicine.medical_specialtyAdolescentVaccination scheduleMeningococcal VaccinesDiseaseBooster doseMeningococcal vaccineVaccination programsYoung AdultMeningococcal C conjugate vaccinesmedicineHumansYoung adultChildImmunization Programsbusiness.industryIncidence (epidemiology)VaccinationSeroprotection studyMiddle AgedAgent-based modellingMeningococcal InfectionsVaccinationInfectious DiseasesImmunizationSpainChild PreschoolFemaleMATEMATICA APLICADAbusinessResearch ArticleBMC Infectious Diseases
researchProduct

Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.

2011

Vaccines are leading pharmacological measures for limiting the impact of pandemic influenza in the community. The objective of this study was to investigate the effectiveness of influenza (pandemic and seasonal) vaccines in preventing pandemic influenza-associated hospitalization. We conducted a multicenter matched case-control study in 36 Spanish hospitals. Patients hospitalized with confirmed pandemic influenza between November 2009 and February 2010 and two hospitalized controls per case, matched according to age, date of hospitalization and province of residence, were selected. Multivariate analysis was performed using conditional logistic regression. Subjects were considered vaccinated…

AdultMalePediatricsmedicine.medical_specialtyMultivariate analysisAdolescentSeasonal influenzaYoung AdultPandemicInfluenza HumanMedicineHumansYoung adultChildAgedAged 80 and overGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthPandemic influenzaCase-control studyInfant Newbornvirus diseasesInfantMiddle AgedHospitalsVaccinationHospitalizationInfectious DiseasesInfluenza VaccinesSpainCase-Control StudiesChild PreschoolImmunologyHuman mortality from H5N1Molecular MedicineFemalebusinessVaccine
researchProduct

Logistic regression of attitudes and coverage for influenza vaccination among Italian Public Health medical residents

2014

Introduction. A few number of literature specifically addresses vaccination uptake among Public Health Residents (PHRs). Influ- enza vaccine attitudes and risk perceptions of PHRs across Italy were studied, contributing to literature on influenza vaccination uptake predictors, in particular among young physicians. Methods. An online survey was conducted in 25 Schools of Public Health in Italy in 2011-2012. Results were analysed using preva- lence and logistic regression methods. Results. A total of 365 Italian public health residents were included in the study. Vaccination uptake was confirmed by 22.2 and 33.2% of PHRs in 2010-2011 and 2011-2012, respectively. For the 2010-2011 influenza se…

AdultMaleRisk perceptionAttitude of Health PersonnelMedical Residents; Influenza vaccination; Risk perceptionInternship and ResidencySettore MED/42 - Igiene Generale E ApplicataInfluenza vaccinationLogistic ModelsItalyInfluenza VaccinesInfluenza HumanHumansOriginal ArticleMedical ResidentsFemalePublic HealthMedical ResidentJournal of Preventive Medicine and Hygiene
researchProduct

Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance net…

2011

SUMMARYEuroRotaNet, a laboratory network, was established in order to determine the diversity of co-circulating rotavirus strains in Europe over three or more rotavirus seasons from 2006/2007 and currently includes 16 countries. This report highlights the tremendous diversity of rotavirus strains co-circulating in the European population during three years of surveillance since 2006/2007 and points to the possible origins of these strains including genetic reassortment and interspecies transmission. Furthermore, the ability of the network to identify strains circulating with an incidence of ⩾1% allowed the identification of possible emerging strains such as G8 and G12 since the beginning of…

AdultMaleRotavirusAdolescentGenotypeEpidemiologyInternational CooperationReassortmentReoviridaemedicine.disease_causeRotavirus InfectionsYoung Adult03 medical and health sciencesSex FactorsPan european[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRotavirusGenotypemedicineHumansChildAged030304 developmental biologyAged 80 and overMolecular Epidemiology0303 health sciencesMolecular epidemiologybiology030306 microbiologyStrain (biology)Incidence (epidemiology)Age FactorsRotavirus VaccinesInfantMiddle Agedbiology.organism_classificationVirology3. Good healthEuropeInfectious DiseasesChild PreschoolPopulation Surveillance[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemaleSeasonsEpidemiology and Infection
researchProduct

Investigate the sexual habits of young people: A cross-sectional study among nursing students of the university of palermo

2019

Introduction: Sexually transmitted diseases are an emerging problem especially among young people, increasing the burden of disease in this population. The aim of the study was to evaluate sexual habits, sexual relations and knowledge of STIs among the students in the nursing science course of the University of Palermo. Materials and Methods: In April 2019, a survey was provided to students that investigate on: personal information and habits, knowledge of sexually transmitted diseases, anti-HPV vaccination. Multivariable logistic regression was performed, considering it as a dependent variable “Have you occasionally had unprotected sex (without a condom)? Yes”, in order to evaluate the rol…

AdultMaleSexual behaviorHealth Knowledge Attitudes PracticeVaccination CoverageUnsafe sexUniversitiessexually transmitted diseasesSex EducationCondomsYoung AdultSurveys and QuestionnairesOdds RatioHumanssexPapillomavirus VaccinesContraception BehaviorSicilyOriginal Article: The Opinions and Needs of Health Professionsnursing studentsquestionnaireCross-Sectional StudiesLogistic ModelsSexual PartnersFemaleStudents NursingexNursing student
researchProduct

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines.

2015

Intracellular cytokine staining combined with flow cytometry is one of a number of assays designed to assess T-cell immune responses. It has the specific advantage of enabling the simultaneous assessment of multiple phenotypic, differentiation and functional parameters pertaining to responding T-cells, most notably, the expression of multiple effector cytokines. These attributes make the technique particularly suitable for the assessment of T-cell immune responses induced by novel tuberculosis vaccines in clinical trials. However, depending upon the particular nature of a given vaccine and trial setting, there are approaches that may be taken at different stages of the assay that are more s…

AdultMaleT-Lymphocytesmedicine.medical_treatmentlcsh:MedicinePeripheral blood mononuclear cellFlow cytometryAdult; Biomarkers; Cytokines; Female; Flow Cytometry; Humans; Male; T-Lymphocytes; Tuberculosis Vaccines; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Tuberculosis VaccineImmune systemmedicineHumansTuberculosis Vaccineslcsh:ScienceCytokineWhole bloodBiochemistry Genetics and Molecular Biology (all)Multidisciplinarybiologymedicine.diagnostic_testlcsh:RBiomarkerSciences bio-médicales et agricolesFlow Cytometry3. Good healthCytokineT-LymphocyteAgricultural and Biological Sciences (all)Immunologybiology.proteinCytokinesBiomarker (medicine)Femalelcsh:QAntibodyTuberculosis vaccinesBiomarkersHumanResearch ArticlePLoS ONE
researchProduct

Increased Vaccination Coverage among Adolescents and Young Adults in the District of Palermo as a Result of a Public Health Strategy to Counteract an…

2018

During the summer of 2016 four cases of invasive meningococcal disease in rapid succession among young adults in the district of Palermo, Italy, resulting in one death, were widely reported by local and national mass media. The resultant ‘epidemic panic’ among the general population overloaded the vaccination units of the Palermo district over the following months. Strategies implemented by the Sicilian and local public health authorities to counteract ‘meningitis fear’ included the following: (a) extension of active and free-of-charge anti-meningococcal tetravalent vaccination from age class 12–18 to 12–30 years old; (b) implementation of vaccination units during normal clinic hours in roo…

AdultMaleVaccination campaign0301 basic medicinemedicine.medical_specialtyVaccination CoverageAdolescentHealth Toxicology and Mutagenesis030106 microbiologyPopulationMeningococcal VaccinesMeningitis MeningococcalMass media; Meningitis; Outbreak; Vaccination campaign; Public Health Environmental and Occupational Health; Health Toxicology and MutagenesisSettore MED/42 - Igiene Generale E ApplicataArticleYoung Adult03 medical and health sciences0302 clinical medicineEnvironmental healthmedicineHumans030212 general & internal medicineYoung adultChildEpidemicseducationMass mediaeducation.field_of_studybusiness.industryPublic healthPublic Health Environmental and Occupational HealthmeningitisPanicOutbreakmedicine.diseasePanicVaccinationMeningitiItalyVaccination coveragemeningitis; vaccination campaign; mass media; outbreakFemalePublic Healthmedicine.symptombusinessMeningitisMass mediaInternational Journal of Environmental Research and Public Health
researchProduct

LOW-DOSE INTERLEUKIN-2 INDUCES SYSTEMIC IMMUNE RESPONSES AGAINST HBsAg IN IMMUNODEFICIENT NON-RESPONDERS TO HEPATITIS B VACCINATION

1989

Abstract A metabolic monocyte defect appears to correlate with non-responsiveness to hepatitis B vaccine in many patients on haemodialysis. This defect prevents production of interleukin-2 during T-cell activation after antigen contact. Receptors for interleukin-2 are, however, expressed in greater numbers than in healthy subjects or uraemic responders to hepatitis B vaccination. In this study, ten uraemic patients, previous non-responders to vaccination against hepatitis B, were revaccinated with the same vaccine combined with one intramuscular injection (2·5 × 10 5 U) of natural human interleukin-2. Systemic production of antibodies against hepatitis B surface antigen was initiated in tho…

AdultMaleViral Hepatitis VaccinesInterleukin 2HBsAgHepatitis B vaccinePilot ProjectsImmunoenzyme TechniquesImmune systemAntigenmedicineHumansHepatitis B VaccinesAgedUremiaHepatitis B Surface Antigensbiologybusiness.industryImmunologic Deficiency SyndromesReceptors Interleukin-2General MedicineMiddle AgedHepatitis Bmedicine.diseaseVirologyVaccinationAntibody FormationImmunologybiology.proteinInterleukin-2FemaleAntibodybusinessmedicine.drugThe Lancet
researchProduct